Viatris Cost of Goods Sold 2010-2024 | VTRS

Viatris annual/quarterly cost of goods sold history and growth rate from 2010 to 2024. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
  • Viatris cost of goods sold for the quarter ending September 30, 2024 was $2.292B, a 1.84% increase year-over-year.
  • Viatris cost of goods sold for the twelve months ending September 30, 2024 was $9.043B, a 3.27% decline year-over-year.
  • Viatris annual cost of goods sold for 2023 was $8.988B, a 7.96% decline from 2022.
  • Viatris annual cost of goods sold for 2022 was $9.766B, a 20.67% decline from 2021.
  • Viatris annual cost of goods sold for 2021 was $12.311B, a 51.07% increase from 2020.
Viatris Annual Cost of Goods Sold
(Millions of US $)
2023 $8,988
2022 $9,766
2021 $12,311
2020 $8,149
2019 $7,603
2018 $7,432
2017 $7,125
2016 $6,380
2015 $5,213
2014 $4,192
2013 $3,869
2012 $3,888
2011 $3,566
2010 $3,233
2009 $3,018
Viatris Quarterly Cost of Goods Sold
(Millions of US $)
2024-09-30 $2,292
2024-06-30 $2,351
2024-03-31 $2,159
2023-12-31 $2,241
2023-09-30 $2,251
2023-06-30 $2,310
2023-03-31 $2,187
2022-12-31 $2,602
2022-09-30 $2,330
2022-06-30 $2,414
2022-03-31 $2,421
2021-12-31 $2,795
2021-09-30 $2,963
2021-06-30 $3,250
2021-03-31 $3,303
2020-12-31 $2,917
2020-09-30 $1,814
2020-06-30 $1,706
2020-03-31 $1,713
2019-12-31 $2,104
2019-09-30 $1,889
2019-06-30 $1,919
2019-03-31 $1,690
2018-12-31 $2,063
2018-09-30 $1,823
2018-06-30 $1,846
2018-03-31 $1,700
2017-12-31 $1,944
2017-09-30 $1,809
2017-06-30 $1,737
2017-03-31 $1,635
2016-12-31 $1,933
2016-09-30 $1,774
2016-06-30 $1,389
2016-03-31 $1,284
2015-12-31 $1,428
2015-09-30 $1,380
2015-06-30 $1,364
2015-03-31 $1,042
2014-12-31 $1,114
2014-09-30 $1,072
2014-06-30 $1,029
2014-03-31 $978
2013-12-31 $1,013
2013-09-30 $959
2013-06-30 $959
2013-03-31 $938
2012-12-31 $981
2012-09-30 $1,009
2012-06-30 $985
2012-03-31 $913
2011-12-31 $887
2011-09-30 $917
2011-06-30 $904
2011-03-31 $858
2010-12-31 $855
2010-09-30 $775
2010-06-30 $827
2010-03-31 $776
2009-12-31 $836
2009-09-30 $759
2009-06-30 $739
2009-03-31 $684
Sector Industry Market Cap Revenue
Medical Medical Services $15.433B $15.427B
Viatris, Inc. is a global healthcare company. Its portfolio comprises more than thousand approved molecules across a wide range of key therapeutic areas, including globally recognized iconic and key brands, generic, complex generic, and biosimilar products. Branded products include EpiPen, Amitiza, Lipitor and Viagra. Biosimilars portfolio include pegfilgrastim, trastuzumab and adalimumab biosimilars. It has obtained approval for the biosimilar of Avastin and Insulin Aspart in Europe. The company reports in following segments: Developed Markets, Greater China, JANZ & Emerging Markets. The Developed Markets segment comprises operations in N. America and Europe. The Greater China segment operates in China, Taiwan and Hong Kong. The JANZ segment will report for operations in Japan, Australia and New Zealand, while the Emerging Markets segment will include operations in Asia, the Middle East, South and Central America, Africa and E. Europe. This segment also includes the company's anti-retroviral franchise.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $95.766B 11.88
Cencora (COR) United States $49.023B 18.08
DiDi Global (DIDIY) China $23.330B 0.00
ICON (ICLR) Ireland $17.511B 15.60
Natera (NTRA) United States $16.712B 0.00
Avantor (AVTR) United States $14.831B 22.24
Revvity (RVTY) United States $14.647B 25.44
BioMerieux (BMXMF) France $12.894B 0.00
CochLear (CHEOY) Australia $12.739B 0.00
Solventum (SOLV) United States $12.214B 0.00
Medpace Holdings (MEDP) United States $11.215B 31.59
Charles River Laboratories (CRL) United States $11.042B 21.34
Doximity (DOCS) United States $10.778B 63.79
HealthEquity (HQY) United States $8.750B 47.49
Sonic Healthcare (SKHHY) Australia $8.450B 0.00
Bausch + Lomb (BLCO) Canada $6.881B 32.03
Life Times (LTH) United States $5.005B 33.12
Sotera Health (SHC) United States $4.402B 23.55
Organon (OGN) United States $4.012B 4.05
Surgery Partners (SGRY) United States $3.759B 42.85
BrightSpring Health Services (BTSG) United States $3.402B 72.37
PACS (PACS) United States $3.129B 0.00
Concentras Parent (CON) United States $2.579B 0.00
Alignment Healthcare (ALHC) United States $2.523B 0.00
Ardent Health Partners (ARDT) United States $2.446B 0.00
Premier (PINC) United States $2.301B 11.48
GeneDx Holdings (WGS) United States $2.113B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
GoodRx Holdings (GDRX) United States $1.783B 47.00
Teladoc Health (TDOC) United States $1.670B 0.00
Progyny (PGNY) United States $1.551B 29.62
Pediatrix Medical (MD) United States $1.331B 13.02
CareDx (CDNA) United States $1.251B 0.00
Establishment Labs Holdings (ESTA) $1.184B 0.00
AMN Healthcare Services Inc (AMN) United States $0.993B 6.72
Embecta (EMBC) United States $0.898B 5.99
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
InnovAge Holding (INNV) United States $0.778B 0.00
Agilon Health (AGL) United States $0.770B 0.00
SBC Medicals (SBC) United States $0.717B 0.00
Auna S.A (AUNA) Luxembourg $0.510B 0.00
Sonida Senior Living (SNDA) United States $0.442B 0.00
DocGo (DCGO) United States $0.426B 16.00
Enhabit (EHAB) United States $0.383B 33.09
COMPASS Pathways (CMPS) United Kingdom $0.346B 0.00
LifeMD (LFMD) United States $0.310B 0.00
ModivCare (MODV) United States $0.244B 13.24
Sera Prognostics (SERA) United States $0.242B 0.00
Beauty Health (SKIN) United States $0.211B 0.00
Nutex Health (NUTX) United States $0.204B 0.00
Biodesix (BDSX) United States $0.204B 0.00
MultiPlan (MPLN) United States $0.141B 0.00
Ascend Wellness Holdings (AAWH) United States $0.120B 0.00
So-Young (SY) China $0.073B 17.77
Singular Genomics Systems (OMIC) United States $0.057B 0.00
Harvard Apparatus Regenerative Technology (HRGN) United States $0.054B 0.00
OncoCyte (OCX) United States $0.051B 0.00
NeueHealth (NEUE) United States $0.042B 1.12
Co-Diagnostics (CODX) United States $0.037B 0.00
Pheton Holdings (PTHL) China $0.029B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.027B 0.00
IceCure Medical (ICCM) Israel $0.027B 0.00
Oncology Institute (TOI) United States $0.022B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
XWELL (XWEL) United States $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.009B 0.00
BioNexus Gene Lab (BGLC) $0.006B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00